@article{king_seewald_forster_friton_adrian_lascelles_2021, title={Clinical safety of robenacoxib in cats with chronic musculoskeletal disease}, volume={7}, ISSN={["1939-1676"]}, DOI={10.1111/jvim.16148}, abstractNote={Abstract}, journal={JOURNAL OF VETERINARY INTERNAL MEDICINE}, author={King, Jonathan N. and Seewald, Wolfgang and Forster, Sophie and Friton, Gabriele and Adrian, Derek E. and Lascelles, B. Duncan X.}, year={2021}, month={Jul} }
 @article{adrian_king_parrish_king_budsberg_gruen_lascelles_2021, title={Robenacoxib shows efficacy for the treatment of chronic degenerative joint disease-associated pain in cats: a randomized and blinded pilot clinical trial}, volume={11}, ISSN={["2045-2322"]}, url={http://dx.doi.org/10.1038/s41598-021-87023-2}, DOI={10.1038/s41598-021-87023-2}, abstractNote={Abstract}, number={1}, journal={Scientific Reports volume}, author={Adrian, D. and King, J.N. and Parrish, R.S. and King, S.B. and Budsberg, S.C. and Gruen, M.E. and Lascelles, B.D.X.}, year={2021}, pages={7721} }
 @article{adrian_rishniw_scherk_lascelles_2018, title={Prescribing Practices of Veterinarians in the Treatment of Chronic Musculoskeletal Pain in Cats}, volume={21}, url={https://doi.org/10.1177/1098612X18787910}, DOI={10.1177/1098612X18787910}, abstractNote={Objectives Despite the high prevalence and increasing awareness of chronic musculoskeletal pain in cats, approved treatment options are completely lacking in the USA, and few other options have sufficient safety and efficacy data. Knowledge of current prescribing practices should inform future research of putative therapies. We aimed to determine which drug and non-drug therapies were being used by general practitioners for the treatment of musculoskeletal pain in cats and to understand demographic influences on prescribing practices. }, number={6}, journal={J Feline Med Surg}, publisher={SAGE Publications}, author={Adrian, D. and Rishniw, M. and Scherk, M. and Lascelles, B.D.X.}, year={2018}, month={Jul}, pages={495–506} }
 @article{adrian_papich_baynes_stafford_lascelles_2018, title={The pharmacokinetics of gabapentin in cats}, volume={32}, ISSN={["1939-1676"]}, url={https://doi.org/10.1111/jvim.15313}, DOI={10.1111/jvim.15313}, abstractNote={BackgroundGabapentin is the most commonly prescribed medication for the treatment of chronic musculoskeletal pain in cats. Despite this common and chronic usage, clinically relevant pharmacokinetic data is lacking.}, number={6}, journal={JOURNAL OF VETERINARY INTERNAL MEDICINE}, publisher={Wiley}, author={Adrian, Derek and Papich, Mark G. and Baynes, Ronald and Stafford, Emma and Lascelles, B. Duncan X.}, year={2018}, pages={1996–2002} }
 @article{adrian_papich_baynes_murrell_lascelles_2017, title={Chronic maladaptive pain in cats: A review of current and future drug treatment options}, volume={230}, ISSN={1090-0233}, url={http://dx.doi.org/10.1016/J.TVJL.2017.08.006}, DOI={10.1016/j.tvjl.2017.08.006}, abstractNote={Despite our increasing understanding of the pathophysiology underlying chronic or maladaptive pain, there is a significant gap in our ability to diagnose and treat the condition in domestic cats. Newer techniques being used to identify abnormalities in pain processing in the cat include validated owner questionnaires, measurement of movement and activity, and measurement of sensory thresholds and somatomotor responses. While some data are available evaluating possible therapeutics for the treatment of chronic pain in the cat, most data are limited to normal cats. This review details our current understanding of chronic or maladaptive pain, techniques for the detection and measurement of the condition and the associated central nervous changes, as well as an overview of the data evaluating potential therapeutics in cats.}, journal={The Veterinary Journal}, publisher={Elsevier BV}, author={Adrian, Derek and Papich, Mark and Baynes, Ron and Murrell, Jo and Lascelles, B. Duncan X.}, year={2017}, month={Dec}, pages={52–61} }